Skip to main content

Want a detailed portfolio tracker?

Savara (SVRA) P/E (2011 - 2026)

Savara (SVRA) P/E from Mar 31, 2011 to Jul 20, 2026. The TTM Savara (SVRA) P/E is -8.42. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Savara (SVRA)

YearP/EChange
2026-8.42-12.82%
2025-9.66+94.62%
2024-4.96-57.15%
2023-11.58+156.61%
2022-4.51+37.57%
2021-3.28+167.94%
2020-1.22-50.05%
2019-2.45-38.15%
2018-3.96-76.75%
2017-17.05-11.85%
2016-19.34-79.35%
2015-93.65-24.95%
2014-124.78+158.44%
2013-48.28+11.27%
2012-43.39+44.26%
2011-30.08N/A

Comparison Savara (SVRA) P/E with competitors

Savara (SVRA) P/E is -8.42.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.05%
ENLVEnlivex Ltd0.07-100.89%
FGENFibroGen Inc0.24-102.85%
CHRSCoherus Biosciences Inc0.85-110.08%
FBIOFortress Biotech Inc0.95-111.27%
ORMPOramed Pharmaceuticals Inc1.50-117.85%
AGENAgenus Inc3.01-135.74%
INVAInnoviva Inc3.15-137.45%
VXRTVaxart Inc3.55-142.15%
CRMDCorMedix Inc3.63-143.09%
CVACCureVac N.V.4.45-152.79%
GLPGGalapagos NV4.86-157.70%
SRPTSarepta Therapeutics Inc4.88-157.97%
ABEOAbeona Therapeutics Inc5.39-163.98%
ABUSArbutus Biopharma Corp5.60-166.45%
ZVRAZevra Therapeutics Inc5.89-169.91%
SPROSpero Therapeutics Inc6.23-173.96%
CGENCompugen Ltd6.31-174.98%
RIGLRigel Pharmaceuticals6.87-181.61%
SLXNSilexion Therapeutics Corp7.30-186.64%
OMEROmeros Corporation9.26-209.95%
AUPHAurinia Pharmaceuticals Inc9.58-213.82%
PLXProtalix BioTherapeutics Inc10.89-229.33%
ACADAcadia Pharmaceuticals Inc11.73-239.28%
TBPHTheravance Biopharma Inc12.26-245.61%
ADMAAdma Biologics Inc12.42-247.46%
HRMYHarmony Biosciences Holdings Inc13.82-264.11%
SABSSAB Biotherapeutics Inc14.14-267.87%
NAGENiagen Bioscience Inc14.82-275.96%
INCYIncyte Corp15.82-287.89%
REGNRegeneron Pharmaceuticals Inc15.86-288.30%
PBYIPuma Biotechnology Inc17.32-305.62%
CPRXCatalyst Pharmaceuticals Inc17.44-307.09%
EXELExelixis Inc17.54-308.26%
TGTXTG Therapeutics Inc18.97-325.22%
MDXGMimedx Group Inc20.55-344.06%
XOMAXOMA Royalty Corp22.87-371.64%
ARGXArgen X SE24.30-388.55%
CTMXCytomX Therapeutics Inc24.82-394.76%
XOMAOXOMA Royalty Corp25.34-400.98%
HALOHalozyme Therapeutics Inc25.62-404.29%
XOMAPXOMA Royalty Corp25.67-404.84%
VRTXVertex Pharmaceuticals Inc27.99-432.45%
RPRXRoyalty Pharma plc - Class A28.69-440.67%
SLNOSoleno Therapeutics Inc29.02-444.57%
ASNDAscendis Pharma A/S30.09-457.27%
LGNDLigand Pharmaceuticals Inc - Class B37.91-550.22%
APLSApellis Pharmaceuticals Inc39.02-563.39%
BMRNBiomarin Pharmaceutical Inc42.21-601.28%
KRYSKrystal Biotech Inc45.34-638.47%
ONCBeiGene Ltd69.54-925.81%
PHARPharming Group N.V.75.03-990.95%
TECHBio-Techne Corp101.96-1310.78%
VCELVericel Corp109.92-1405.35%
ALNYAlnylam Pharmaceuticals Inc117.96-1500.87%
GMABGenmab140.29-1765.99%
TLXTelix Pharmaceuticals Ltd162.15-2025.61%
CORTCorcept Therapeutics Inc212.86-2627.74%